News
Bringing Precision Medicine to Ophthalmology
Innovative device ensures doctors obtain adequate fluid samples from the eye, helping with diagnosis and individualized treatment plans for patients.
1 in 3 Parents Plan to Skip Flu Shots for Their Kids During COVID-19 Pandemic
National Poll finds COVID-19 may not influence parents’ beliefs about the flu vaccine, with just 1/3 believing it’s more important for children to get vaccinated in 2020.
ECMO: Last-Resort Life Support Option Helped Majority of Critically Ill COVID-19 Patients Survive, Global Study Shows
ECMO outcomes study at experienced centers suggests key role for treating worst-hit patients as pandemic continues.
Nonalcoholic Fatty Liver Disease and Heart Failure: Is There a Connection?
A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Scientists Train Computers to Recognize Which Early Stage Breast Cancers Will Spread
The new approach could help doctors to separate aggressive stage 0 breast cancer from non-aggressive forms, sparing some women unnecessary mastectomies.
Firearms research at U-M gets a $4.6M boost with three new grants from CDC
In a milestone of research funding, three teams of University of Michigan researchers have received funding from the Centers for Disease Control and Prevention to address issues related to firearm injury.
A 4-Year-Old’s Journey with Sickle Cell Disease
After Shavonn Burgess got her daughter’s diagnosis, she had no idea how her family would cope. Now, after a year of blood transfusions and spleen removal, they’ve found a new normal.
Hail Fellows, Well Met!
Though they often receive little fanfare, postdocs are critical to the success of the Rogel Cancer Center’s research programs.
Boy With Cleft Lip Adopts Puppy With Cleft Lip: “It Was Meant to Be”
A chance visit to a local animal shelter leads one Mott Children’s patient family to the perfect pet match for their 2-year-old son.
Uncovering a ‘suPAR’ culprit behind kidney injury in COVID-19
A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.
